Momenta

J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win
BioSpace
Mon, 06/17/24 - 11:36 am
JNJ
clinical trials
nipocalimab
Sjögren’s syndrome
Momenta
J&J clears PhII for rare blood disorder with drug from $6.5B Momenta buyout
Endpoints
Mon, 02/6/23 - 10:41 am
JNJ
Momenta
Janssen
nipocalimab
clinical trials
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
The top 5 pharma M&A deals of 2020
Pharmaforum
Mon, 12/21/20 - 11:07 am
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Fierce Pharma
Wed, 06/19/19 - 10:57 pm
Sanofi
bloodthinners
Lovenox
generics
Amphastar
Momenta
Sandoz
Momenta Moves On
Motley Fool
Fri, 11/16/18 - 07:58 pm
Momenta
earnings
biosimilars
M281
M254
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
Momenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows
Yahoo/Zacks.com
Fri, 11/3/17 - 09:07 am
Momenta
earnings
biosimilars
M834
Orencia
Teva catches break as warning letter looks to delay Momenta Copaxone generic
Fierce Pharma
Mon, 02/20/17 - 10:06 am
Teva Pharmaceutical
Momenta
Copaxone
MS
multiple sclerosis
generics
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Shire
biosimilars
Humira
Enbrel
Momenta
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
Mylan, Momenta Team Up To Develop Biosimilar Drugs
Investors.com
Sat, 01/9/16 - 10:32 am
Mylan Labs
Momenta
biosimilars
R&D
Novartis off to scorching start with Copaxone generic Glatopa
Fierce Pharma Marketing
Mon, 07/13/15 - 11:11 am
Novartis
Copaxone
generics
Glatopa
MS
multiple scleroiss
Momenta
Sandoz
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Teva Pharmaceutical
Momenta
Sandoz
generics
Novartis
Copaxone
MS
multiple sclerosis
U.S. court nixes Teva's Copaxone patent--again
Fierce Pharma
Thu, 06/18/15 - 04:00 pm
Copaxone
patents
Teva Pharmaceuticals
generics
Momenta
Novartis
Sandoz
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
Momenta reports 1Q loss
Yahoo/AP
Fri, 05/1/15 - 09:49 am
Momenta
earnings
Drugmakers Oppose Teva Bid to Delay Copaxone Rivals
Bloomberg
Mon, 04/14/14 - 07:08 pm
Teva
Copaxone
MS
multiple sclerosis
Momenta
generics
Sandoz
Mylan
Momenta Pharmaceuticals Slumps: MNTA Falls 16.9% in Session
Yahoo/Zacks.com
Tue, 04/1/14 - 08:05 am
Momenta
Supreme Court to decide patent dispute over multiple sclerosis treatment
Yahoo/AP
Mon, 03/31/14 - 11:00 am
Supreme Court
MS
multiple sclerosis
Copaxone
Teva Pharmaceuticals
Sandoz
Mylan
Momenta

Pages